Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lower Protamine Dose for Reversal of Heparin After Cardiopulmonary Bypass
NCT07477977Recruiting
- Sponsor
- Sohag University
- Start
- Mar 2026
- Primary completion
- Jun 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of protamine in heparin-induced thrombocytopenia (HIT) (3 arms), sponsored by Sohag University. Primary endpoint: Activated Clotting Time at 5 minutes. Started Mar 2026; status: recruiting.
02
Drugs
protamine
03
Conditions
heparin-induced thrombocytopenia (HIT)
Beyond the preview
Go deeper on NCT07477977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07477977.